Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGL PYGM	6.99e-06	3	31	2	GO:0008184
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGL PYGM	2.33e-05	5	31	2	GO:0004645
GeneOntologyMolecularFunction	RNA polymerase I general transcription initiation factor activity	UBTFL6 UBTF	8.34e-05	9	31	2	GO:0001181
GeneOntologyMolecularFunction	RNA polymerase I core promoter sequence-specific DNA binding	UBTFL6 UBTF	1.27e-04	11	31	2	GO:0001164
GeneOntologyMolecularFunction	RNA polymerase I transcription regulatory region sequence-specific DNA binding	UBTFL6 UBTF	1.80e-04	13	31	2	GO:0001163
GeneOntologyMolecularFunction	AMP binding	PYGL PYGM	4.81e-04	21	31	2	GO:0016208
GeneOntologyBiologicalProcess	negative regulation of cell-matrix adhesion	POSTN DUSP22 CORO1C	3.64e-05	43	31	3	GO:0001953
GeneOntologyBiologicalProcess	RNA polymerase I preinitiation complex assembly	UBTFL6 UBTF	1.19e-04	11	31	2	GO:0001188
GeneOntologyBiologicalProcess	negative regulation of cell-substrate adhesion	POSTN DUSP22 CORO1C	1.85e-04	74	31	3	GO:0010812
GeneOntologyBiologicalProcess	negative regulation of substrate adhesion-dependent cell spreading	POSTN CORO1C	2.27e-04	15	31	2	GO:1900025
GeneOntologyBiologicalProcess	negative regulation of focal adhesion assembly	DUSP22 CORO1C	2.93e-04	17	31	2	GO:0051895
GeneOntologyBiologicalProcess	negative regulation of cell-substrate junction organization	DUSP22 CORO1C	2.93e-04	17	31	2	GO:0150118
GeneOntologyBiologicalProcess	membrane invagination	FNBP1L ITGAM GSN	2.99e-04	87	31	3	GO:0010324
GeneOntologyBiologicalProcess	transcription initiation at RNA polymerase I promoter	UBTFL6 UBTF	3.29e-04	18	31	2	GO:0006361
GeneOntologyCellularComponent	NuRD complex	CHD4 CDK2AP2	2.85e-04	17	31	2	GO:0016581
GeneOntologyCellularComponent	CHD-type complex	CHD4 CDK2AP2	2.85e-04	17	31	2	GO:0090545
GeneOntologyCellularComponent	lamellipodium	CDC42BPB DUSP22 CORO1C GSN	3.56e-04	230	31	4	GO:0030027
HumanPheno	Tapered finger	CHD4 TCF20 WNK1 CDC42BPB KDM5C	5.17e-05	141	16	5	HP:0001182
HumanPheno	Aggressive behavior	LMAN2L TCF20 PRDM16 CDC42BPB UBTF KDM5C NAA20 ALG13	6.48e-05	516	16	8	HP:0000718
HumanPheno	Abnormal aggressive, impulsive or violent behavior	LMAN2L TCF20 PRDM16 CDC42BPB UBTF KDM5C NAA20 ALG13	6.48e-05	516	16	8	HP:0006919
Domain	Glyco_trans_35	PYGL PYGM	7.99e-06	3	31	2	IPR000811
Domain	PHOSPHORYLASE	PYGL PYGM	7.99e-06	3	31	2	PS00102
Domain	Phosphorylase	PYGL PYGM	7.99e-06	3	31	2	PF00343
Domain	Glycg_phsphrylas	PYGL PYGM	7.99e-06	3	31	2	IPR011833
Domain	HMG_box_dom	CHD4 UBTFL6 UBTF	1.69e-04	65	31	3	IPR009071
Domain	PHD	CHD4 TCF20 KDM5C	4.27e-04	89	31	3	SM00249
Domain	Znf_PHD	CHD4 TCF20 KDM5C	4.56e-04	91	31	3	IPR001965
Domain	ZF_PHD_2	CHD4 TCF20 KDM5C	5.17e-04	95	31	3	PS50016
Domain	ZF_PHD_1	CHD4 TCF20 KDM5C	5.33e-04	96	31	3	PS01359
Domain	Znf_FYVE_PHD	CHD4 TCF20 KDM5C	1.83e-03	147	31	3	IPR011011
Domain	HMG_box	UBTFL6 UBTF	3.49e-03	53	31	2	PF00505
Domain	HMG_BOX_2	UBTFL6 UBTF	3.62e-03	54	31	2	PS50118
Domain	HMG	UBTFL6 UBTF	3.62e-03	54	31	2	SM00398
Domain	Zinc_finger_PHD-type_CS	CHD4 KDM5C	5.20e-03	65	31	2	IPR019786
Domain	PHD	CHD4 KDM5C	6.86e-03	75	31	2	PF00628
Domain	Znf_PHD-finger	CHD4 KDM5C	7.59e-03	79	31	2	IPR019787
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION	PYGL PYGM	1.08e-04	9	25	2	M47621
Pathway	BIOCARTA_FEEDER_PATHWAY	PYGL PYGM	1.08e-04	9	25	2	M3061
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGL PYGM	2.71e-04	14	25	2	MM15391
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PYGL PYGM	2.71e-04	14	25	2	M19193
Pathway	REACTOME_GLYCOGEN_METABOLISM	PYGL PYGM	4.54e-04	18	25	2	MM15577
Pathway	REACTOME_GLYCOGEN_METABOLISM	PYGL PYGM	8.83e-04	25	25	2	M27857
Pubmed	Integrin αM activation and upregulation on esophageal eosinophils and periostin-mediated eosinophil survival in eosinophilic esophagitis.	POSTN ITGAM	7.69e-07	2	31	2	29424023
Pubmed	Microspherule protein 1, Mi-2beta, and RET finger protein associate in the nucleolus and up-regulate ribosomal gene transcription.	CHD4 UBTF	7.68e-06	5	31	2	16186106
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CHD4 TCF20 MYCBP2 UBTF CORO1C GSN NCBP3	2.66e-05	1024	31	7	24711643
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	PYGL CHD4 TCF20 MYCBP2 UBTF CORO1C GSN	4.27e-05	1103	31	7	34189442
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	WNK1 MYCBP2 PRDM16 CDC42BPB	4.68e-05	225	31	4	12168954
Pubmed	Critical roles of transcriptional coactivator MED1 in the formation and function of mouse adipose tissues.	ITGAM PRDM16	5.96e-05	13	31	2	33888560
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	CHD4 MRPL3 CORO1C GSN ALG13	6.38e-05	483	31	5	36912080
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	PYGM CHD4 WNK1 MYCBP2 CDC42BPB	7.30e-05	497	31	5	23414517
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	UBTF KDM5C CORO1C MAP3K4 NCBP3	7.30e-05	497	31	5	36774506
Pubmed	Localization of the muscle, liver, and brain glycogen phosphorylase genes on linkage maps of mouse chromosomes 19, 12, and 2, respectively.	PYGL PYGM	8.02e-05	15	31	2	2575583
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	CHD4 TCF20 UBTF	1.07e-04	103	31	3	32744500
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	PYGL CHD4 FNBP1L ITGAM WNK1 CORO1C GSN	1.64e-04	1367	31	7	32687490
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CHD4 TCF20 MYCBP2 CDC42BPB CORO1C GSN	1.81e-04	963	31	6	28671696
Pubmed	PRDM16 expression and function in mammalian cochlear development.	PRDM16 GSN	1.92e-04	23	31	2	35451126
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	BCL9L CHD4 CDC42BPB KDM5C	2.09e-04	332	31	4	37433992
Pubmed	Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif.	MYCBP2 CDC42BPB	2.28e-04	25	31	2	12522145
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	CHD4 ITGAM WNK1 CORO1C	2.40e-04	344	31	4	30333137
Pubmed	Analysis of a lung defect in autophagy-deficient mouse strains.	PYGL PYGM	2.47e-04	26	31	2	24275123
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	PYGL CHD4 TCF20 MYCBP2 UBTF	2.61e-04	653	31	5	22586326
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	POSTN MYCBP2 CDC42BPB DUSP22 UBTF CORO1C	2.86e-04	1049	31	6	27880917
Pubmed	Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.	POSTN MYCBP2	2.86e-04	28	31	2	25158072
Pubmed	Characterising the dynamics of placental glycogen stores in the mouse.	PYGL PYGM	3.08e-04	29	31	2	32798765
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	CHD4 CORO1C GSN NCBP3	3.16e-04	370	31	4	22922362
Pubmed	Glycogen Dynamics Drives Lipid Droplet Biogenesis during Brown Adipocyte Differentiation.	PYGL PRDM16	3.29e-04	30	31	2	31693883
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LMAN2L WNK1 MYCBP2 PRDM16 CDC42BPB SUMF1	3.78e-04	1105	31	6	35748872
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TCF20 CWC25 WNK1 MYCBP2 CORO1C	4.42e-04	733	31	5	34672954
Pubmed	Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.	CHD4 CDK2AP2	5.30e-04	38	31	2	33283408
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	CHD4 MYCBP2 UBTF MAP3K4	6.07e-04	440	31	4	34244565
Pubmed	HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stress.	CORO1C GSN	6.17e-04	41	31	2	24614889
Pubmed	Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates.	CHD4 WNK1	6.17e-04	41	31	2	15561718
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	BCL9L WNK1 CORO1C ALG13	6.38e-04	446	31	4	24255178
Pubmed	14-3-3 proteins sequester a pool of soluble TRIM32 ubiquitin ligase to repress autoubiquitylation and cytoplasmic body formation.	WNK1 MYCBP2	6.47e-04	42	31	2	23444366
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	CHD4 MYCBP2 CORO1C GSN ALG13	6.84e-04	807	31	5	30575818
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	FNBP1L WNK1 MYCBP2 NCBP3	7.28e-04	462	31	4	31138677
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	CHD4 MYCBP2 CDC42BPB	7.70e-04	202	31	3	24639526
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BCL9L LMAN2L UBTF NCBP3	7.70e-04	469	31	4	27634302
Pubmed	A human MAP kinase interactome.	TCF20 WNK1 CDC42BPB MAP3K4	8.79e-04	486	31	4	20936779
Interaction	SPATA1 interactions	WNK1 KDM5C MAP3K4	1.30e-05	31	30	3	int:SPATA1
Interaction	DNAH6 interactions	CORO1C NAA20 GSN	2.06e-05	36	30	3	int:DNAH6
Interaction	GATAD2B interactions	CHD4 CDK2AP2 TCF20 CWC25 PRDM16	2.83e-05	245	30	5	int:GATAD2B
Interaction	IQCA1 interactions	IQCA1 ALG13	5.96e-05	8	30	2	int:IQCA1
Interaction	JPH3 interactions	CWC25 UBTF NCBP3	7.41e-05	55	30	3	int:JPH3
Interaction	SENP3 interactions	PYGL MYCBP2 PRDM16 UBTF NCBP3	7.54e-05	301	30	5	int:SENP3
Cytoband	2q11.2	UBTFL6 LMAN2L	1.10e-03	72	31	2	2q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr12p13	CHD4 ACSM4 WNK1	1.73e-03	353	31	3	chr12p13
Cytoband	Ensembl 112 genes in cytogenetic band chr2q11	UBTFL6 LMAN2L	4.82e-03	153	31	2	chr2q11
GeneFamily	Glycogen phosphorylases	PYGL PYGM	3.14e-06	3	19	2	437
GeneFamily	PHD finger proteins	CHD4 KDM5C	3.97e-03	90	19	2	88
Coexpression	GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP	CHD4 TCF20 WNK1 UBTF NAA20	3.00e-06	200	30	5	M4050
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	PYGM CHD4 WNK1 MYCBP2 UBTF	3.47e-06	206	30	5	M2817
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	PYGM CHD4 WNK1 MYCBP2 UBTF	3.64e-06	208	30	5	MM581
Coexpression	GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	GLRA3 RESP18 IQCA1 KDM5C	1.08e-05	121	30	4	M9153
Coexpression	GSE20727_CTRL_VS_H2O2_TREATED_DC_DN	PYGM CHD4 MYCBP2 CDC42BPB	7.14e-05	196	30	4	M9243
Coexpression	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	CHD4 WNK1 UBTF KDM5C	7.57e-05	199	30	4	M2155
Coexpression	MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	CHD4 WNK1 UBTF KDM5C	7.57e-05	199	30	4	MM991
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN	GLRA3 PYGM CHD4 CDK2AP2	7.57e-05	199	30	4	M5240
Coexpression	GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN	PYGL ITGAM CORO1C GSN	7.72e-05	200	30	4	M4624
Coexpression	GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP	GLRA3 LMAN2L MYCBP2 NAA20	7.72e-05	200	30	4	M9360
Coexpression	GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN	LMAN2L CORO1C SUMF1 GSN	7.72e-05	200	30	4	M7162
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP	BCL9L TCF20 KDM5C NAA20	7.72e-05	200	30	4	M4016
ToppCell	3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage\|GI_small-bowel / Manually curated celltypes from each tissue	PYGL CDC42BPB CORO1C GSN	6.56e-06	176	31	4	4be270f6bb7da4070f972aca403109751646d155
ToppCell	ASK454-Epithelial-Type_2\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	UBTF NCBP3	3.02e-05	12	31	2	f8ea75314b9fa2bdc57564cad9640893a47f0340
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	1.49e-04	149	31	3	2a2a5673ce4f376e7b25f2bc8127fb7e260f37af
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	1.49e-04	149	31	3	c9f02ec62a658a751e591699f9395fe597e22a2e
ToppCell	facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYGL CDK2AP2 ITGAM	1.62e-04	153	31	3	338684d420b01e32918fa19048ccdda234942ce1
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	1.68e-04	155	31	3	3f31f3c37eb40d5467def8506e349fa4b4695833
ToppCell	facs-Lung-EPCAM-24m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 ITGAM	1.74e-04	157	31	3	d2cb261a9ee2c90e2e0fc656bd6413fbccb465fc
ToppCell	facs-Lung-24m-Hematologic-myeloid-neutrophil\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYGL CDK2AP2 ITGAM	1.74e-04	157	31	3	e96241db2b5ff52b230e3e33207e7bb968900cab
ToppCell	facs-Lung-EPCAM-24m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 ITGAM	1.74e-04	157	31	3	350069e4d2dbddc82e813e2a2cc43032daa23605
ToppCell	facs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYGL CDK2AP2 ITGAM	1.74e-04	157	31	3	07a0f8d29a3111be670eae030a91474465eba734
ToppCell	droplet-Spleen-nan-24m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	1.78e-04	158	31	3	72e4f8ae137a7dddee0dc6236532e0711065e6af
ToppCell	droplet-Spleen-nan-24m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	1.78e-04	158	31	3	e1a8dba5a88bc3ce112829c5ecb112cbbee5b078
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.02e-04	165	31	3	1d844d19ff9b49dd0f61f0b24799e172076771ef
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.02e-04	165	31	3	9a6abd0e6b11860231ce5e845c87b8d66f3ef697
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.02e-04	165	31	3	9acf03b5a20170721380045b5c268825e8f315dd
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.02e-04	165	31	3	433771abefc5bcb89bdae64af45cce7407bffe5d
ToppCell	droplet-Marrow-BM-1m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.05e-04	166	31	3	758817f38e843db4ef6ab3e2bfb9f1a2075c9af9
ToppCell	droplet-Marrow-BM-30m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.05e-04	166	31	3	019d365df44c3bbd88c1f4bdceb3de0ff76d3e8d
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Hematologic-proerythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 GSN	2.05e-04	166	31	3	a1211afc1197d078eb3db0d0f788ecaf4419aa5b
ToppCell	facs-Marrow-T_cells-18m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.05e-04	166	31	3	fab4da2537904ad114218f720e18a600f14a00a1
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.13e-04	168	31	3	3611605114f6b668b44728d6563cd02389e106af
ToppCell	Immune_cells-Neutrophils\|Immune_cells / Lineage and Cell class	PYGL ITGAM GSN	2.13e-04	168	31	3	3539f802fe0143da1462df0618f78f9f15143f71
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.13e-04	168	31	3	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.17e-04	169	31	3	f38b52972a6c492ce2fd520a26bb3fc8db23bf85
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.17e-04	169	31	3	1000eaf5158596b4898bedcc802b31db76b05a48
ToppCell	facs-BAT-Fat-18m-Myeloid-granulocyte\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 ITGAM	2.17e-04	169	31	3	d3e6c75e5eda133fb6535cfe6c6a1026641f26ac
ToppCell	facs-Marrow-Granulocytes-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.17e-04	169	31	3	ee1969755180df58d32904e2bb4192da9373d03e
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.17e-04	169	31	3	c6750c45c44be68aea39e918ba97c6f875ccea34
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.17e-04	169	31	3	1077fbca61bd0c1f9706aeb0552b77362127f261
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.17e-04	169	31	3	70c841a7b1e3f665105d715a6d72762c80ce5de2
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.17e-04	169	31	3	15d5758d94a14a909d1d0c8bba9ce497a33d1512
ToppCell	facs-Marrow-Granulocytes-24m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.17e-04	169	31	3	5320da1d61806b53e0bd96bbdfdb8fd69246681b
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.17e-04	169	31	3	83b854fa8fd9017df8f9207d9ced260eee98e8c1
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.24e-04	171	31	3	ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6
ToppCell	facs-Marrow-Granulocytes\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.24e-04	171	31	3	1701dedf0c18751db6c9fee3d93fff150ed0e17f
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.24e-04	171	31	3	97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3
ToppCell	droplet-Lung-18m-Hematologic-myeloid\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PYGL CDK2AP2 ITGAM	2.24e-04	171	31	3	33869b9fab2c94cb33f1cc659073fcf2bb30c22d
ToppCell	droplet-Marrow-BM-1m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.24e-04	171	31	3	8a0c08f0aa3a80cd6346c81deb242e430ebd897b
ToppCell	facs-BAT-Fat-18m-Myeloid\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 ITGAM	2.28e-04	172	31	3	8e91831804a120037c71cd4e74af686f3c32d31c
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.28e-04	172	31	3	e72966ced5f2ee9e24ce9fd820d99a69a482a607
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.28e-04	172	31	3	83730ea3b240b8e2f2a9fb6c34dd1408050867ff
ToppCell	facs-BAT-Fat-18m-Myeloid-myeloid_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL CDK2AP2 ITGAM	2.28e-04	172	31	3	ea4da9aab7a2ff854df21da01d11c9ed99e41fb4
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.32e-04	173	31	3	0f9784b30c81a4a4940e0623cec60d596e9985d2
ToppCell	facs-Marrow-T_cells-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.32e-04	173	31	3	60f79e0698a7cf7516690fb20f1b82ee46547699
ToppCell	droplet-Marrow-nan-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.36e-04	174	31	3	4b749ac9f05776c0c56b74daca833bd0b5704299
ToppCell	PND07-Immune\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL CDK2AP2 ITGAM	2.44e-04	176	31	3	2f87f49b64c6f89823d540172a8e923ebaa6d6cd
ToppCell	droplet-Marrow-nan-21m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.44e-04	176	31	3	f7d8eb90489a6d22240179abeb0aa16ac24615d3
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.48e-04	177	31	3	065bebd22031f143e90a407f952b444a3f8818c7
ToppCell	facs-Marrow-Granulocytes-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.48e-04	177	31	3	eb304f20aab075bd17aa3aef819386c0e1a235bd
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	PYGL ITGAM GSN	2.69e-04	182	31	3	52eac2f892ea7f26731e0b21c578fd2665a1657a
ToppCell	3'_v3-bone_marrow-Myeloid_Mac\|bone_marrow / Manually curated celltypes from each tissue	CDC42BPB CORO1C GSN	2.69e-04	182	31	3	e1d6b5de5bd1d11e968da3a55e5326ef252f55ba
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PYGL ITGAM GSN	2.69e-04	182	31	3	243c783675df495ea4112dbf710712c44ea6b4f1
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PYGL ITGAM GSN	2.69e-04	182	31	3	18790a394dc32b3cef99cdbf826392c520e38b4a
ToppCell	droplet-Marrow-nan-21m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.74e-04	183	31	3	71ea92cd20683230af314ff883b2624bd68382e1
ToppCell	droplet-Marrow-nan-21m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.78e-04	184	31	3	d071f53ad9e957dc0f8ae9c53aaa31cfebcf815e
ToppCell	mild-Myeloid-Immature_Neutrophils_1\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PYGL ITGAM GSN	2.82e-04	185	31	3	d747bc91fc276f12a5572ab0223fc71f829a5110
ToppCell	droplet-Marrow-nan-21m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PYGL ITGAM GSN	2.92e-04	187	31	3	20b25b0d08550a1e8e997c5ce67d8e34bf7fc398
ToppCell	PND03\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PYGL ITGAM WNK1	2.92e-04	187	31	3	b3fcb36d853adfdea7172c5591de06f027e50af3
ToppCell	mild-Myeloid-Immature_Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PYGL ITGAM GSN	3.01e-04	189	31	3	94dd5d4d815449feff7ce157fe7f8234f7c81422
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PYGL ITGAM GSN	3.01e-04	189	31	3	3b35022c0619df6db234613aa53a076899ca9562
ToppCell	PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PYGL ITGAM GSN	3.01e-04	189	31	3	358ff514f1c8aa46067208ddf1b68396d789c130
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.05e-04	190	31	3	896b5825edb30fe62cbbed6078570c1f8057a99e
ToppCell	control-Myeloid-Immature_Neutrophils_1\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PYGL ITGAM GSN	3.05e-04	190	31	3	38e83337c70c8734b63f8589ba59e0f98603f94c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PYGL PRDM16 GSN	3.10e-04	191	31	3	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.10e-04	191	31	3	d4f77c73311d1149466bbfe4adbd6a301946ec90
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.20e-04	193	31	3	e1855cff9a6bcfda9188b9fdf6c9d698405da990
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	POSTN PYGL GSN	3.20e-04	193	31	3	b6f5a85210e60798205eaf5884cdb540f549d08a
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	POSTN PYGL GSN	3.20e-04	193	31	3	e1de67ddada87229f5db0ec193a6da8745a86a64
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PYGL ITGAM CORO1C	3.20e-04	193	31	3	52f5b0fbb8ca706206c65e7edbb1ddbd380aebae
ToppCell	Macrophages-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ITGAM CORO1C GSN	3.20e-04	193	31	3	642f8f20e5a35a4b5d1fc8d3f1e3b9b83a37a654
ToppCell	356C-Myeloid-Macrophage\|356C / Donor, Lineage, Cell class and subclass (all cells)	CORO1C NAA20 GSN	3.25e-04	194	31	3	3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage\|367C / Donor, Lineage, Cell class and subclass (all cells)	ITGAM CORO1C NAA20	3.25e-04	194	31	3	40c91ed945bd5990a0dbf2090d37a660b19aaab2
ToppCell	E12.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PYGL CORO1C GSN	3.30e-04	195	31	3	bff7685784688425bebd78b0f284a6d4475a9415
ToppCell	E12.5-Mesenchymal-myocytic_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PYGL CORO1C GSN	3.30e-04	195	31	3	aed243418cdb5df4563a7b935c1ecbd744590901
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 DUSP22 GSN	3.30e-04	195	31	3	c54b19e31efe2c9ae690062569da7c0f1120a1d8
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD4 RESP18 MYCBP2	3.30e-04	195	31	3	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-myeloid\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.30e-04	195	31	3	b0dbaae86f5703ab62f925e0f36500274044884a
ToppCell	severe-Myeloid-Immature_Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PYGL ITGAM GSN	3.30e-04	195	31	3	becad890a420267ca41e98e61a8da343b51e1945
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD4 RESP18 MYCBP2	3.30e-04	195	31	3	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAM GSN NCBP3	3.30e-04	195	31	3	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	COVID-19_Severe-Neu_2\|World / 5 Neutrophil clusters in COVID-19 patients	PYGL ITGAM GSN	3.34e-04	196	31	3	16359a56297f0558fc93fa52563cce0c53def167
ToppCell	droplet-Tongue-TONGUE\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNK1 MYCBP2 GSN	3.34e-04	196	31	3	44a30b1a5f3d8c845e5f3bd17d8102a7449f555b
ToppCell	3'_v3-Lung\|World / Manually curated celltypes from each tissue	CDC42BPB CORO1C GSN	3.34e-04	196	31	3	a04f8384b734ce67ec402e64bd891a6274f04744
ToppCell	droplet-Tongue-TONGUE-1m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNK1 MYCBP2 GSN	3.34e-04	196	31	3	9935bdb10789e8cfc922dca526ca3bf8317fe270
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WNK1 MYCBP2 GSN	3.34e-04	196	31	3	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	facs-Skin-Telogen-3m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POSTN PYGL GSN	3.34e-04	196	31	3	c936014125b2ed5f796221b74acb77b8f8359875
ToppCell	343B-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CORO1C NAA20 GSN	3.40e-04	197	31	3	1b6f7a62b7fcfd55c25c5840353eed7183050860
ToppCell	myeloid-pro-pDC\|World / Lineage and Cell class	CDK2AP2 CORO1C GSN	3.40e-04	197	31	3	8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5
ToppCell	MS-mono1\|MS / Condition, Cell_class and T cell subcluster	PYGL ITGAM GSN	3.40e-04	197	31	3	32be48ee2a1397ed8f1ee8e60067dd9a96bece39
ToppCell	MS-mono1-\|MS / Condition, Cell_class and T cell subcluster	PYGL ITGAM GSN	3.40e-04	197	31	3	4b038a193ecc1df65bcb608091c513ddafd6c818
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.40e-04	197	31	3	b91016249b3585aa3536e96af18e4f1b1d2d5ce4
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PYGL ITGAM GSN	3.40e-04	197	31	3	ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9
ToppCell	367C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CORO1C NAA20 GSN	3.40e-04	197	31	3	f5c21f0d363b5c298a2b82f6dff4f369397b5f25
ToppCell	T/NK_cells-CD56dim_NK_cell\|T/NK_cells / Lineage and Cell class	CDK2AP2 ITGAM GSN	3.40e-04	197	31	3	722d00a218755cc8cb7b5ab2a7fca40269247c3a
ToppCell	COVID-19_Severe-Neu_2\|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients	PYGL ITGAM GSN	3.40e-04	197	31	3	945f19475905cdedf232315eea1076ca0b753b67
ToppCell	356C-Myeloid-Macrophage\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CORO1C NAA20 GSN	3.40e-04	197	31	3	896242e1651435bbc5b6521417e1aca36c215acd
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGAM CORO1C GSN	3.45e-04	198	31	3	f3a12a7e23bb4ff6e82fee675dbc090d99587f69
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PYGL ITGAM GSN	3.45e-04	198	31	3	82f6ac18c3a6487f03579b5c247844f1c115c2be
ToppCell	10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PYGL ITGAM GSN	3.45e-04	198	31	3	3bc05b8d97a7219af40db7a11aa271f02e74fca5
ToppCell	Severe-B_memory-3\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	GLRA3 ITGAM GSN	3.45e-04	198	31	3	a3050c126799e32f742a14396236572250476820
Drug	1-N-Acetyl-Beta-D-Glucosamine	PYGL PYGM	1.68e-06	2	30	2	DB02320
Drug	AC1L3XPY	POSTN PYGL PYGM	2.70e-06	21	30	3	CID000124005
Drug	3,5-dimethylphenyl isocyanate	PYGL PYGM	5.03e-06	3	30	2	CID000521488
Drug	3'-FFdUrd	PYGL PYGM	5.03e-06	3	30	2	CID000072260
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGL PYGM	5.03e-06	3	30	2	CID000093111
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGL PYGM	5.03e-06	3	30	2	CID000119518
Drug	adenosine-5'-chloromethylphosphonate	PYGL PYGM	5.03e-06	3	30	2	CID000191554
Drug	AC1L8XK3	PYGL PYGM	5.03e-06	3	30	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGL PYGM	5.03e-06	3	30	2	CID000446801
Drug	hydan	PYGL PYGM	5.03e-06	3	30	2	CID000008360
Drug	EHMF	PYGL PYGM	5.03e-06	3	30	2	CID000033931
Drug	NSC758405	PYGL PYGM	5.03e-06	3	30	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGL PYGM	5.03e-06	3	30	2	CID000151920
Drug	riboflavin tetraacetate	PYGL PYGM	5.03e-06	3	30	2	CID000094186
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGL PYGM	5.03e-06	3	30	2	CID000147839
Drug	pyridoxal phosphoglucose	PYGL PYGM	5.03e-06	3	30	2	CID000196007
Drug	pyridoxal 5'-methylenephosphonate	PYGL PYGM	5.03e-06	3	30	2	CID003082249
Drug	2,5-dimethyl-3-furanone	PYGL PYGM	5.03e-06	3	30	2	CID000085730
Drug	Plp 5'-mpa	PYGL PYGM	5.03e-06	3	30	2	CID003082151
Drug	3,5-dinitrophenol	PYGL PYGM	5.03e-06	3	30	2	CID000011459
Drug	glucose-1,2-cyclic phosphate	PYGL PYGM	5.03e-06	3	30	2	CID000191723
Drug	4-nitrobiphenyl	POSTN TCF20 UBTF	6.61e-06	28	30	3	CID000007114
Drug	galocitabine	PYGL PYGM	1.01e-05	4	30	2	CID000065950
Drug	uric acid riboside	PYGL PYGM	1.01e-05	4	30	2	CID000164933
Drug	pseudo-dl-glucose	PYGL PYGM	1.01e-05	4	30	2	CID000125259
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGL PYGM	1.01e-05	4	30	2	CID000189134
Drug	AC1LAMW2	PYGL PYGM	1.01e-05	4	30	2	CID000491364
Drug	FdUrd-C8	PYGL PYGM	1.01e-05	4	30	2	CID000094262
Drug	BCIp4A	PYGL PYGM	1.01e-05	4	30	2	CID000192417
Drug	Mem-CC	PYGL PYGM	1.01e-05	4	30	2	CID003081269
Drug	pyridoxal diphosphate	PYGL PYGM	1.01e-05	4	30	2	CID000125696
Drug	5-deoxyribose-1-phosphate	PYGL PYGM	1.01e-05	4	30	2	CID000135786
Drug	3'-chloromethotrexate	PYGL PYGM	1.01e-05	4	30	2	CID000097703
Drug	ingliforib	PYGL PYGM	1.01e-05	4	30	2	CID006451325
Drug	phosphorite	POSTN PYGL PYGM	1.20e-05	34	30	3	CID000107908
Drug	heptulose-2-P	PYGL PYGM	1.67e-05	5	30	2	CID000124823
Drug	m-anisidine	PYGL PYGM	1.67e-05	5	30	2	CID000010824
Drug	indirubin-5-sulphonate	PYGL PYGM	1.67e-05	5	30	2	CID005288641
Drug	6-FPLP	PYGL PYGM	1.67e-05	5	30	2	CID000146246
Drug	gluconohydroximo-1,5-lactone	PYGL PYGM	1.67e-05	5	30	2	CID009576855
Drug	2-hydroxypropylphosphonate	PYGL PYGM	1.67e-05	5	30	2	CID000441028
Drug	DHPBU	PYGL PYGM	1.67e-05	5	30	2	CID000125914
Drug	6-FDPL	PYGL PYGM	1.67e-05	5	30	2	CID000129578
Drug	AC1O3M08	PYGL PYGM	1.67e-05	5	30	2	CID006331955
Drug	AC1LCUXJ	PYGL PYGM	1.67e-05	5	30	2	CID000656425
Drug	6-amino-5-bromouracil	PYGL PYGM	1.67e-05	5	30	2	CID000080578
Drug	5'-isobutylthioinosine	PYGL PYGM	1.67e-05	5	30	2	CID003080910
Drug	etafenone	PYGL PYGM	1.67e-05	5	30	2	CID000003275
Drug	ddEtUrd	PYGL PYGM	1.67e-05	5	30	2	CID000451452
Drug	5-trifluoromethyl-2'-deoxycytidine	PYGL PYGM	1.67e-05	5	30	2	CID000125618
Drug	3'-O-methylpyridoxal 5'-phosphate	PYGL PYGM	1.67e-05	5	30	2	CID003082179
Drug	GlcMan	PYGL PYGM	1.67e-05	5	30	2	CID000152120
Drug	U66985	PYGL PYGM	1.67e-05	5	30	2	CID000127224
Drug	maltohexaose	POSTN PYGL PYGM	1.83e-05	39	30	3	CID000439606
Drug	2,2-dimethyl-3-hydroxybutyric acid	PYGL PYGM	2.51e-05	6	30	2	CID000152984
Drug	CV-araU	PYGL PYGM	2.51e-05	6	30	2	CID006441877
Drug	EdUMP	PYGL PYGM	2.51e-05	6	30	2	CID003085112
Drug	2-thiothymidine	PYGL PYGM	2.51e-05	6	30	2	CID003005944
Drug	4-hydroxyacetophenone	PYGL PYGM	2.51e-05	6	30	2	ctd:C031335
Drug	5'-deoxy-5'-chloroformycin	PYGL PYGM	2.51e-05	6	30	2	CID000126430
Drug	NSC-97433	PYGL PYGM	2.51e-05	6	30	2	CID000001803
Drug	5-n-propylthioadenosine	PYGL PYGM	2.51e-05	6	30	2	CID000656428
Drug	AzddCyd	PYGL PYGM	2.51e-05	6	30	2	CID000451374
Drug	5-Ffdru	PYGL PYGM	2.51e-05	6	30	2	CID000065561
Drug	AR-L57	PYGL PYGM	2.51e-05	6	30	2	CID000156890
Drug	Carbocyclic Ivdu	PYGL PYGM	2.51e-05	6	30	2	CID006439191
Drug	Carbocyclic Bvdc	PYGL PYGM	2.51e-05	6	30	2	CID006438602
Drug	DNPP	PYGL PYGM	2.51e-05	6	30	2	CID000067056
Drug	5-chloro-indole-2-carboxylic acid	PYGL PYGM	2.51e-05	6	30	2	CID000082693
Drug	alpha-(fluoromethyl)dehydroornithine	PYGL PYGM	3.51e-05	7	30	2	CID006439607
Drug	1 Gpt	PYGL PYGM	3.51e-05	7	30	2	CID000101247
Drug	6-fluoropyridoxal	PYGL PYGM	3.51e-05	7	30	2	CID003080803
Drug	formycins	PYGL PYGM	3.51e-05	7	30	2	CID000512867
Drug	Promonta	PYGL PYGM	3.51e-05	7	30	2	CID000108494
Drug	2',3'-dideoxy-3'-fluorocytidine	PYGL PYGM	3.51e-05	7	30	2	CID000356019
Drug	heptenitol	PYGL PYGM	3.51e-05	7	30	2	CID000188267
Drug	5'-methylthioinosine	PYGL PYGM	3.51e-05	7	30	2	CID000161214
Drug	AC1L3372	PYGL PYGM	3.51e-05	7	30	2	CID000108025
Drug	hydantocidin	PYGL PYGM	3.51e-05	7	30	2	CID000125429
Drug	Glycan	POSTN PYGL PYGM ITGAM	4.12e-05	148	30	4	CID000000871
Drug	6-methylpurine	PYGL PYGM	4.68e-05	8	30	2	CID005287547
Drug	amorphin	PYGL PYGM	4.68e-05	8	30	2	CID000122792
Drug	Etafenone [inn]	PYGL PYGM	4.68e-05	8	30	2	CID000066659
Drug	AC1NUVX5	PYGL PYGM	4.68e-05	8	30	2	CID005461894
Drug	5'-iodo-5'-deoxyadenosine	PYGL PYGM	6.01e-05	9	30	2	CID000107502
Drug	6-benzyl-2-thiouracil	PYGL PYGM	6.01e-05	9	30	2	CID000685814
Drug	Phosphonoserine	PYGL PYGM	6.01e-05	9	30	2	DB04522
Drug	5'-methylthiotubercidin	PYGL PYGM	6.01e-05	9	30	2	CID000188350
Drug	alpha-maltosyl fluoride	PYGL PYGM	6.01e-05	9	30	2	CID000194237
Drug	5-Iodoribose 1-phosphate	PYGL PYGM	6.01e-05	9	30	2	CID003035973
Drug	8-azidoadenosine 5'-monophosphate	PYGL PYGM	7.50e-05	10	30	2	CID000124726
Drug	2,6-dihydroxypyridine	PYGL PYGM	7.50e-05	10	30	2	CID000069371
Drug	6-methyluridine	PYGL PYGM	7.50e-05	10	30	2	CID000092887
Drug	UDP-pyridoxal	PYGL PYGM	7.50e-05	10	30	2	CID000126789
Drug	mannan	POSTN PYGL PYGM	7.77e-05	63	30	3	CID000000870
Drug	9 Da	PYGL PYGM	9.16e-05	11	30	2	CID005287565
Drug	glucosyl fluoride	PYGL PYGM	9.16e-05	11	30	2	CID000150967
Drug	Cid 11299980	PYGL PYGM	9.16e-05	11	30	2	CID009856533
Drug	acyclothymidine	PYGL PYGM	1.10e-04	12	30	2	CID000072358
Drug	5'-deoxypyridoxal	PYGL PYGM	1.10e-04	12	30	2	CID000164889
Disease	Developmental delay (disorder)	TCF20 UBTF KDM5C	7.96e-06	37	31	3	C0424605
Disease	abdominal aortic aneurysm (is_marker_for)	POSTN ITGAM	4.78e-05	10	31	2	DOID:7693 (is_marker_for)
Disease	cerebral infarction (is_marker_for)	ITGAM GSN	1.81e-04	19	31	2	DOID:3526 (is_marker_for)
Disease	Epilepsy	LMAN2L KDM5C ALG13	2.04e-04	109	31	3	C0014544
Disease	Global developmental delay	TCF20 UBTF KDM5C	3.67e-04	133	31	3	C0557874
Disease	Glycogen Storage Disease	PYGL PYGM	3.69e-04	27	31	2	C0017919
Disease	empathy measurement	FNBP1L CWC25 SUMF1	7.50e-04	170	31	3	EFO_0009183
Disease	Intellectual Disability	LMAN2L TCF20 KDM5C ALG13	1.18e-03	447	31	4	C3714756
Disease	pre-eclampsia (is_marker_for)	ITGAM GSN	1.70e-03	58	31	2	DOID:10591 (is_marker_for)
Disease	Endometrial Neoplasms	CHD4 MAP3K4	1.70e-03	58	31	2	C0014170
Disease	IGA glomerulonephritis	ITGAM DUSP22	1.70e-03	58	31	2	EFO_0004194
Disease	Endometrial Carcinoma	CHD4 MAP3K4	2.61e-03	72	31	2	C0476089

Protein segments in the cluster

Peptide	Gene	Start	Entry
AMPSRKGRGYQKMPG	ALG13	556	Q9NP73
KEEKLDWMYQGPGGM	CWC25	66	Q9NXE8
KEPQRGMGYMPKRGL	CORO1C	311	Q9ULV4
EIKPGSMGKGMLPYD	ACSM4	386	P0C7M7
GKYPGKNGLQMMLHA	IQCA1	606	Q86XH1
YGMGPCLQAKDGMTP	GLRA3	386	O75311
AEAPGGELMGYIMGK	NAA20	46	P61599
MKYGNPNYGGMKGIL	NCBP3	281	Q53F19
KDRMQPGPVFGNMDK	LMAN2L	136	Q9H0V9
EILQAMEDGMGKYGP	CDC42BPB	246	Q9Y5S2
SYGGLDMMQAPGPSK	RESP18	191	Q5W5W9
MGYVQAMKPPGAQGS	CDK2AP2	56	O75956
MKDVYEKNPQMGDPG	FNBP1L	431	Q5T0N5
MGKAMAGRMGDAYPP	BCL9L	1281	Q86UU0
MGNGMNKILPGLYIG	DUSP22	1	Q9NRW4
MSLFGGKPMIIYKGG	GSN	536	P06396
EAPKMPNGMYDGSAL	CHD4	1031	Q14839
VWPGTKMPGKMGNIY	MRPL3	251	P09001
NFQIMYKVGMGHKPP	MAP3K4	1551	Q9Y6R4
EKYFGPGFMGMQEKK	PRDM16	701	Q9HAZ2
PGFMGMQEKKLGSLP	PRDM16	706	Q9HAZ2
MPFLRGGPGMYKVVK	MYCBP2	2581	O75592
QYKDMMSEGGPPGAE	ITGAM	1136	P11215
PPSGKDRVKKGGSYM	SUMF1	321	Q8NBK3
YAKGKNMAMMGGPAP	UBTFL6	311	P0CB48
IGGKAAPGYHMAKMI	PYGM	606	P11217
LKNDKDGMMYGPPVG	TCF20	1136	Q9UGU0
KGHMNYEGPGMARKF	WNK1	2271	Q9H4A3
MKFQGEPKKPPMNGY	UBTF	561	P17480
PGYMRMEGMKGCPAV	POSTN	81	Q15063
IGGKAAPGYHMAKMI	PYGL	606	P06737
LQIYGAGPKMMGLGL	KDM5C	236	P41229